Lupin balance sheet

As of Mar 2026

Total assets: ₹38,365cr+31.4% on Mar 2025
Shareholders' equity: ₹22,513cr+30.2% on Mar 2025
Total debt: ₹5,910cr+16.4% on Mar 2025
Cash and investments: ₹7,745cr+197.6% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	5,449	5,148	4,899	4,645
	695	355	596	895
	2,659	2,233	2,325	2,219
	2,886	2,339	1,655	1,491
	321	161	177	343
	29.0	27.7	26.9	30.1
	63.6	59.6	201	47.1
	2.1	3.3	3.6	4.0
	1,452	1,293	119	98.7
	1,517	1,356	324	150
	565	559	303	156
	217	227	245	576
	14,337	12,406	10,550	10,505
	6,083	5,476	4,954	4,492
	3,577	1,059	847	440
	6,604	5,497	4,692	4,481
	4,168	1,544	983	1,232
	1,485	1,599	219	61.3
	2.9	5.0	2.6	2.1
	563	332	638	556
	16,400	10,036	7,383	6,772
	1,543	1,252	1,071	1,151
	24,027	16,799	13,448	12,451
	38,365	29,205	23,997	22,956
Equity
	91.4	91.3	91.1	91.0
	22,357	17,112	14,199	12,374
	22,448	17,204	14,290	12,465
	65.1	90.9	83.2	78.3
	22,513	17,294	14,373	12,543
Liabilities
	1,643	1,766	0.0	27.5
	548	316	312	388
	2,191	2,082	312	415
	533	436	375	343
	219	226	246	229
	258	205	189	160
	3,200	2,949	1,122	1,148
	4,267	3,310	2,670	4,217
	4,173	2,958	2,958	2,532
	1,333	839	776	706
	9,773	7,108	6,404	7,454
	561	273	525	515
	668	440	429	425
	1,649	1,140	1,144	871
	12,651	8,961	8,502	9,265
	15,851	11,911	9,624	10,413
	38,365	29,205	23,997	22,956
Assets — additional as-filed lines
	1.5	34.6	40.6	36.7
Trade payables — MSME split
	157	85.9	—	—
	4,016	2,872	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LUPIN₹1,972.70

Lupin Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA CIPLA DRREDDY ALKEM FORTIS AUROPHARMA LAURUSLABS MANKINDMcap ₹90,192 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	4,645.0	4,898.6	5,148.2	5,449.1	5,449.1
+ Capital Work-in-Progress	894.8	595.7	355.5	695.2	695.2
+ Goodwill	2,218.8	2,325.0	2,232.6	2,658.5	2,658.5
+ Other Intangibles	1,491.4	1,654.7	2,338.6	2,886.3	2,886.3
+ Intangibles under Development	343.2	176.9	161.2	321.0	321.0
+ Investments (Equity Method)	30.1	26.9	27.7	29.0	29.0
+ Non-current Investments	47.1	200.8	59.6	63.6	63.6
+ Long-term Loans	4.0	3.6	3.3	2.1	2.1
+ Other Non-current Financial Assets	98.7	119.4	1,293.5	1,451.6	1,451.6
Non-current Financial Assets	149.8	323.8	1,356.3	1,517.3	1,517.3
+ Deferred Tax Assets	155.7	302.5	559.1	564.7	564.7
+ Other Non-current Assets	575.9	245.5	227.2	216.5	216.5
Total Non-current Assets	10,504.6	10,549.5	12,406.3	14,337.5	14,337.5
Current Assets
+ Inventories	4,491.8	4,953.9	5,476.4	6,083.3	6,083.3
+ Current Investments	439.8	846.9	1,059.1	3,577.1	3,577.1
+ Trade Receivables	4,480.7	4,692.1	5,497.1	6,604.1	6,604.1
+ Cash & Cash Equivalents	1,231.8	983.3	1,543.7	4,167.7	4,167.7
+ Other Bank Balances	61.3	219.3	1,598.6	1,485.2	1,485.2
+ Short-term Loans	2.1	2.6	5.0	2.9	2.9
+ Other Current Financial Assets	556.1	638.5	332.1	563.0	563.0
Current Financial Assets	6,771.8	7,382.6	10,035.7	16,400.0	16,400.0
+ Other Current Assets	1,151.0	1,070.6	1,251.9	1,542.7	1,542.7
Total Current Assets	12,451.3	13,447.7	16,798.6	24,027.4	24,027.4
Total Assets	22,955.9	23,997.2	29,204.9	38,364.8	38,364.8
Equity
+ Equity Share Capital	91.0	91.1	91.3	91.4	91.4
+ Other Equity / Reserves	12,373.5	14,199.2	17,112.2	22,356.8	22,356.8
Equity — Owners of Parent	12,464.5	14,290.3	17,203.5	22,448.3	22,448.3
+ Minority Interest	78.3	83.2	90.9	65.1	65.1
Total Equity	12,542.8	14,373.5	17,294.4	22,513.4	22,513.4
Liabilities
+ Borrowings — Non-current	27.5	0.0	1,766.2	1,643.4	1,643.4
+ Other Non-current Financial Liab	387.8	311.6	315.9	547.5	547.5
Non-current Financial Liabilities	415.3	311.6	2,082.1	2,190.9	2,190.9
+ Provisions — Non-current	343.0	375.4	436.1	532.7	532.7
+ Deferred Tax Liabilities	229.4	245.9	226.4	218.8	218.8
+ Other Non-current Liabilities	160.0	189.4	204.5	257.8	257.8
Non-current Liabilities	1,147.7	1,122.2	2,949.1	3,200.2	3,200.2
+ Borrowings — Current	4,216.5	2,669.9	3,310.4	4,266.8	4,266.8
+ Trade Payables	2,531.5	2,958.1	2,958.2	4,173.1	4,173.1
+ Other Current Financial Liab	706.3	775.5	839.3	1,333.1	1,333.1
Current Financial Liabilities	7,454.4	6,403.5	7,107.9	9,773.1	9,773.1
+ Provisions — Current	515.1	524.9	273.2	561.2	561.2
+ Current Tax Liabilities	425.0	429.1	440.2	668.0	668.0
+ Other Current Liabilities	870.9	1,143.9	1,140.1	1,648.9	1,648.9
Current Liabilities	9,265.4	8,501.5	8,961.4	12,651.2	12,651.2
Total Liabilities	10,413.1	9,623.7	11,910.5	15,851.5	15,851.5
Total Equity & Liabilities	22,955.9	23,997.2	29,204.9	38,364.8	38,364.8
Assets — additional as-filed lines
+ Current Tax Assets	36.7	40.6	34.6	1.5	1.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	85.9	157.3	157.3
+ Dues to Other Creditors — Current	—	—	2,872.3	4,015.8	4,015.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.